Timothy Bushnell
Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Neoplastic Stem Cells | 3 | 2007 | 21 |
Why?
| Flow Cytometry | 3 | 2008 | 216 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2007 | 33 |
Why?
| Signal Transduction | 5 | 2002 | 313 |
Why?
| Mice | 12 | 2001 | 623 |
Why?
| Blast Crisis | 2 | 2007 | 12 |
Why?
| Antigen-Presenting Cells | 2 | 2007 | 40 |
Why?
| Erythroblasts | 2 | 2005 | 13 |
Why?
| B-Lymphocytes | 2 | 2001 | 134 |
Why?
| Cell Lineage | 2 | 2007 | 60 |
Why?
| Mucin-1 | 1 | 2009 | 12 |
Why?
| Flagellin | 1 | 2009 | 6 |
Why?
| Toll-Like Receptors | 1 | 2009 | 19 |
Why?
| Fetus | 2 | 2007 | 105 |
Why?
| Neuroendocrine Tumors | 1 | 2009 | 4 |
Why?
| Antigens, CD44 | 1 | 2009 | 18 |
Why?
| Dermoscopy | 1 | 2008 | 3 |
Why?
| Nobel Prize | 1 | 2008 | 5 |
Why?
| Lymphoid Progenitor Cells | 1 | 2008 | 4 |
Why?
| Fusion Proteins, bcr-abl | 1 | 2008 | 10 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 15 |
Why?
| Gene Deletion | 1 | 2009 | 121 |
Why?
| Image Cytometry | 1 | 2008 | 6 |
Why?
| E2F2 Transcription Factor | 1 | 2008 | 1 |
Why?
| Hematopoietic System | 1 | 2008 | 9 |
Why?
| Dendritic Cells | 1 | 2009 | 60 |
Why?
| Lipopolysaccharides | 1 | 2009 | 98 |
Why?
| Erythroid Cells | 1 | 2008 | 8 |
Why?
| Animals | 14 | 2001 | 1031 |
Why?
| Cell Differentiation | 4 | 2001 | 262 |
Why?
| Thiadiazoles | 1 | 2007 | 8 |
Why?
| Green Fluorescent Proteins | 1 | 2008 | 105 |
Why?
| Phagocytes | 1 | 2007 | 19 |
Why?
| Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 10 |
Why?
| Lymphocyte Activation | 2 | 2001 | 137 |
Why?
| Diagnostic Imaging | 1 | 2008 | 66 |
Why?
| Cell Transformation, Neoplastic | 1 | 2008 | 86 |
Why?
| Erythropoiesis | 1 | 2007 | 25 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 45 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2007 | 21 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2007 | 26 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2007 | 34 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 28 |
Why?
| Lymphocytes | 1 | 2008 | 142 |
Why?
| Cell Communication | 1 | 2007 | 72 |
Why?
| Lymphoma, B-Cell | 1 | 2007 | 33 |
Why?
| Mice, Knockout | 5 | 2002 | 265 |
Why?
| Orthomyxoviridae Infections | 1 | 2007 | 29 |
Why?
| Genes, Switch | 1 | 2005 | 7 |
Why?
| Histocompatibility Antigens Class II | 1 | 2007 | 50 |
Why?
| Cyclooxygenase 2 | 1 | 2007 | 77 |
Why?
| Hematopoietic Stem Cells | 1 | 2008 | 69 |
Why?
| Globins | 1 | 2005 | 21 |
Why?
| Glutathione | 1 | 2007 | 65 |
Why?
| Interferon-gamma | 1 | 2007 | 133 |
Why?
| Mice, Transgenic | 4 | 2007 | 209 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2007 | 23 |
Why?
| Oxidative Stress | 1 | 2007 | 119 |
Why?
| T-Lymphocytes | 1 | 2007 | 182 |
Why?
| Prostatic Neoplasms | 1 | 2009 | 120 |
Why?
| Proline | 1 | 2002 | 30 |
Why?
| Gene Expression Regulation | 1 | 2008 | 277 |
Why?
| Doxycycline | 1 | 2001 | 34 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 67 |
Why?
| Glycoproteins | 1 | 2002 | 113 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 49 |
Why?
| Mice, Inbred C57BL | 4 | 2001 | 318 |
Why?
| Osteoclasts | 1 | 2002 | 48 |
Why?
| Stem Cells | 1 | 2002 | 107 |
Why?
| NF-kappa B | 1 | 2002 | 114 |
Why?
| Anti-Bacterial Agents | 1 | 2001 | 195 |
Why?
| Cell Line, Tumor | 2 | 2007 | 208 |
Why?
| Up-Regulation | 2 | 2007 | 183 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 243 |
Why?
| Disease Models, Animal | 2 | 2007 | 349 |
Why?
| Cells, Cultured | 3 | 2001 | 447 |
Why?
| Mice, Inbred BALB C | 2 | 2001 | 176 |
Why?
| Spleen | 2 | 2001 | 129 |
Why?
| Toll-Like Receptor 5 | 1 | 2009 | 5 |
Why?
| Toll-Like Receptor 4 | 1 | 2009 | 14 |
Why?
| Chromogranin A | 1 | 2009 | 8 |
Why?
| Phosphopyruvate Hydratase | 1 | 2009 | 24 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 36 |
Why?
| Immunity, Innate | 1 | 2009 | 60 |
Why?
| Female | 4 | 2007 | 1643 |
Why?
| History, 21st Century | 1 | 2008 | 36 |
Why?
| Ikaros Transcription Factor | 1 | 2008 | 1 |
Why?
| Ligands | 1 | 2009 | 116 |
Why?
| Myeloid Cells | 1 | 2008 | 9 |
Why?
| Immunophenotyping | 1 | 2008 | 66 |
Why?
| DNA Fragmentation | 1 | 2007 | 35 |
Why?
| fms-Like Tyrosine Kinase 3 | 1 | 2007 | 5 |
Why?
| Talin | 1 | 2007 | 5 |
Why?
| Humans | 5 | 2007 | 1856 |
Why?
| Mice, Inbred ICR | 1 | 2007 | 34 |
Why?
| Isoxazoles | 1 | 2007 | 15 |
Why?
| Embryonic Development | 1 | 2007 | 26 |
Why?
| Antigens, CD45 | 1 | 2007 | 30 |
Why?
| Antigens, CD11b | 1 | 2007 | 12 |
Why?
| Sulfones | 1 | 2007 | 23 |
Why?
| Glutamate-Cysteine Ligase | 1 | 2007 | 17 |
Why?
| History, 20th Century | 1 | 2008 | 111 |
Why?
| Yolk Sac | 1 | 2007 | 13 |
Why?
| Catalytic Domain | 1 | 2007 | 27 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2007 | 39 |
Why?
| Pyrazoles | 1 | 2007 | 42 |
Why?
| Pneumonia, Viral | 1 | 2007 | 17 |
Why?
| Sulfhydryl Compounds | 1 | 2007 | 42 |
Why?
| Cell Separation | 1 | 2008 | 110 |
Why?
| Receptors, Chemokine | 1 | 2007 | 24 |
Why?
| Response Elements | 1 | 2007 | 40 |
Why?
| Mice, SCID | 1 | 2007 | 61 |
Why?
| Cell Death | 1 | 2007 | 94 |
Why?
| Sulfonamides | 1 | 2007 | 74 |
Why?
| Adjuvants, Immunologic | 1 | 2007 | 73 |
Why?
| RNA Polymerase II | 1 | 2005 | 14 |
Why?
| Histone Acetyltransferases | 1 | 2005 | 20 |
Why?
| Cell Cycle | 1 | 2007 | 121 |
Why?
| Cell Cycle Proteins | 1 | 2008 | 71 |
Why?
| Protein Kinase C | 1 | 2007 | 93 |
Why?
| Cell Survival | 1 | 2007 | 229 |
Why?
| Tetrachlorodibenzodioxin | 1 | 2007 | 18 |
Why?
| Immunohistochemistry | 1 | 2009 | 355 |
Why?
| Cell Membrane | 1 | 2007 | 170 |
Why?
| Survival Rate | 1 | 2007 | 250 |
Why?
| Reactive Oxygen Species | 1 | 2007 | 112 |
Why?
| Tumor Cells, Cultured | 1 | 2007 | 233 |
Why?
| Embryo, Mammalian | 1 | 2005 | 99 |
Why?
| Phenotype | 1 | 2007 | 303 |
Why?
| Erythrocytes | 1 | 2005 | 109 |
Why?
| Protein Binding | 1 | 2007 | 256 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 431 |
Why?
| Histones | 1 | 2005 | 42 |
Why?
| Cell Proliferation | 1 | 2007 | 227 |
Why?
| Cytokines | 1 | 2007 | 207 |
Why?
| Liver | 1 | 2008 | 248 |
Why?
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 2002 | 5 |
Why?
| Receptors, Interleukin-6 | 1 | 2002 | 6 |
Why?
| Thiocarbamates | 1 | 2002 | 9 |
Why?
| Leupeptins | 1 | 2002 | 14 |
Why?
| Retrospective Studies | 1 | 2009 | 653 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2002 | 17 |
Why?
| NF-kappa B p50 Subunit | 1 | 2002 | 23 |
Why?
| Pregnancy | 1 | 2007 | 455 |
Why?
| Stromal Cells | 1 | 2002 | 41 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2002 | 22 |
Why?
| Osteoprotegerin | 1 | 2002 | 18 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 53 |
Why?
| Gene Rearrangement, B-Lymphocyte | 1 | 2001 | 13 |
Why?
| Immunoglobulin Isotypes | 1 | 2001 | 17 |
Why?
| Immunoglobulin Class Switching | 1 | 2001 | 17 |
Why?
| RANK Ligand | 1 | 2002 | 30 |
Why?
| Bone Marrow Cells | 1 | 2002 | 92 |
Why?
| Interleukin-1 | 1 | 2002 | 109 |
Why?
| Antioxidants | 1 | 2002 | 84 |
Why?
| Male | 2 | 2008 | 1553 |
Why?
| Interleukin-6 | 1 | 2002 | 145 |
Why?
| RNA, Messenger | 1 | 2007 | 394 |
Why?
| Membrane Glycoproteins | 1 | 2002 | 154 |
Why?
| Immunoglobulin G | 1 | 2001 | 191 |
Why?
| Biological Markers | 1 | 2001 | 262 |
Why?
| Cell Division | 1 | 2001 | 273 |
Why?
| Carrier Proteins | 1 | 2002 | 177 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2002 | 210 |
Why?
| Apoptosis | 1 | 2002 | 265 |
Why?
|
|
Bushnell's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
